[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349487-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349487-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","temporal-trends-in-cause-specific-cardiovascular-disease-mortality-following-cancer-diagnosis","Temporal Trends in Cause-Specific Cardiovascular Disease Mortality Following Cancer Diagnosis","","Background: This study analyzes temporal trends in cardiovascular disease (CVD) mortality after cancer diagnosis, stratified by disease type, cancer type, and demographic characteristics. Methods: Individuals diagnosed between January 2016 and June 2020 were analyzed using Japan’s National Cancer Registry, with standardized mortality ratios (SMRs) versus age- and sex-matched general-population expectations. Outcomes covered myocardial infarction, heart diseases, ischemic and hemorrhagic stroke, and all-cause CVD mortality.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/temporal-trends-in-cause-specific-cardiovascular-disease-mortality-following-cancer-diagnosis/349487/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/temporal-trends-in-cause-specific-cardiovascular-disease-mortality-following-cancer-diagnosis/349487.png","ImageObject",300,407,{"name":42,"@type":43},"Guten tag","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study designed to evaluate after cancer diagnosis?","Question",{"text":63,"@type":64},"To quantify temporal trends in cardiovascular disease mortality after cancer diagnosis, stratified by disease type, cancer type, and demographic characteristics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data source and study period were used?",{"text":68,"@type":64},"Data came from Japan’s National Cancer Registry, including individuals diagnosed between January 2016 and June 2020.",{"name":70,"@type":61,"acceptedAnswer":71},"How were cardiovascular deaths and risk estimates defined?",{"text":72,"@type":64},"Cardiovascular mortality outcomes were defined using ICD-10 codes, and standardized mortality ratios (SMRs) compared observed CVD deaths with expected deaths in an age- and sex-matched general population.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349487,1790326738,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nTemporal Trends in Cause-Specific Cardiovascular Disease Mortality Following Cancer Diagnosis  \nKen Kurisu1,2,3  | Maiko Fujimori2  | Saki Harashima2,3 | Tatsuo Akechi4 | Kazuhiro Yoshiuchi3 | Yosuke Uchitomi1  \n1Department of Cancer Survivorship and Digital Medicine, Jikei University School of Medicine, Tokyo, Japan | 2Division of Survivorship Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan | 3Department of Stress Sciences and Psychosomatic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan | 4Department of Psychiatry and Cognitive-Behavioral Medicine, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan  \nCorrespondence: Maiko Fujimori ([mfujimor@ncc.go.jp](mfujimor@ncc.go.jp))  \nReceived: 17 August 2025 | Revised: 30 June 2026 | Accepted: 1 July 2026  \nKeywords: cancer | cardiovascular mortality | myocardial infarction | National Cancer Registry | population-based study | stroke  \nABSTRACT  \nBackground: This study analyzed temporal trends in cardiovascular disease (CVD) mortality, stratified by disease type, cancer type, and demographic characteristics.  \nMethods: Individuals diagnosed with cancer between January 2016 and June 2020 were analyzed using data from the National Cancer Registry in Japan. Standardized mortality ratios (SMRs) were calculated by comparing observed CVD deaths among individuals with cancer to expected deaths in the age-and sex-matched general population. Outcomes included myocardial infarction, other heart diseases, ischemic stroke, hemorrhagic stroke, and all-cause CVD mortality. Multivariable Cox models were developed to estimate hazard ratios for the covariates.  \nResults: The analysis included 4,711,540 individuals and 70,630 CVD deaths during the follow-up period. Across all outcomes, SMRs peaked 0–1 month after diagnosis (e.g., 2.35 for all CVDs) and declined sharply by 6 months (e.g., 1.18 for all CVDs) . For several CVD outcomes, a secondary increase in SMRs was observed at approximately 37–48 months (e.g., 1.30 for all CVDs) . Although the number of deaths for each CVD was higher among older individuals, SMRs were greater in younger age groups. The five most common cancers accounted for approximately half of all deaths and showed similar temporal trends. Cox models achieved moderate predictive accuracy, and adjusted hazard ratios were higher for regional metastasis, distant metastasis, and unknown/other categories than for localized tumors.  \nConclusions: This study revealed detailed temporal patterns of CVD mortality following cancer diagnosis, particularly during acute phases.  \n1 | Introduction  \nPopulation-based studies have demonstrated that individuals diagnosed with cancer have an elevated risk of cardiovascular mortality worldwide [1] . This risk is highest during the first month after diagnosis [2–4] . Following this initial period, the risk declines rapidly [2–4], before rising again several years later [5–7] . Cardiotoxicity from cancer treatment, especially chemotherapy, has been identified as a contributing mechanism for  \ncardiovascular mortality among individuals with cancer [8], and targeted interventions have been specifically investigated [9] .  \nHowever, the mechanisms underlying cardiovascular mortality during the first month after diagnosis, a critical period of highest risk, remain unclear. Moreover, preventive countermeasures for this period remain unexplored. As one clue toa possible mechanism, the temporal trend, characterized by a sharp increase within the first month of diagnosis followed  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2026 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2026;","cbCaia4lfm5YJP8P","https://ap.wps.com/l/cbCaia4lfm5YJP8P","pdf",1634467,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Study Participants and Outcomes","[{\"question\":\"What was the study designed to evaluate after cancer diagnosis?\",\"answer\":\"To quantify temporal trends in cardiovascular disease mortality after cancer diagnosis, stratified by disease type, cancer type, and demographic characteristics.\"},{\"question\":\"Which data source and study period were used?\",\"answer\":\"Data came from Japan’s National Cancer Registry, including individuals diagnosed between January 2016 and June 2020.\"},{\"question\":\"How were cardiovascular deaths and risk estimates defined?\",\"answer\":\"Cardiovascular mortality outcomes were defined using ICD-10 codes, and standardized mortality ratios (SMRs) compared observed CVD deaths with expected deaths in an age- and sex-matched general population.\"}]","Temporal Trends in Cause-Specific Cardiovascular Disease Mortality Following Cancer Diagnosis | PDF",1790083512,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b3aad58196a56866ba486956c672bf8.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82c36f6c853ccc997c82b48a403bba69.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdd776c7b16b90e3f5f8a680472f1fc9.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07f5b418a8cabe5833b16425a4ba40a9.webp",980,1287]